Coaching AOD 9604
$235.00
Quantity
Includes medical consult, personalized dosing plan, and expert coaching
This package includes access to a licensed telehealth provider through our partner, Qualiphy, and expert coaching to help accelerate your fat loss and metabolic health. All prescriptions are issued only if medically appropriate after an independent medical review. If you're not approved, you’ll receive a full refund. Renu does not prescribe or sell medication directly. All peptides are fulfilled exclusively by licensed U.S. compounding pharmacies.
AOD-9604 (Advanced Obesity Drug) is a modified peptide fragment derived from human growth hormone (HGH), engineered specifically to trigger fat loss without impacting IGF-1 or insulin levels. It promotes targeted lipolysis and prevents lipogenesis, helping reduce stubborn body fat safely.
Originally developed by Monash University, AOD-9604 offers all the fat-burning benefits of HGH—without the side effects tied to growth hormone therapy.
🔥 Stimulates Lipolysis Promotes the breakdown of stored fat—particularly in stubborn areas like the abdomen, hips, and thighs.
🛑 Inhibits Lipogenesis Helps prevent the formation of new fat cells, even during caloric surplus.
⚖️ Non-GH-Mimetic Does not elevate IGF-1 or disrupt insulin sensitivity, making it safer for long-term use.
🧩 Supports Cartilage & Joint Health Some studies suggest AOD-9604 may help with cartilage repair and inflammation reduction.
✅ Accelerated fat loss, especially in resistant areas ✅ No effect on IGF-1, blood sugar, or growth factors ✅ Can be safely stacked with other peptides (e.g., CJC-1295, MOTS-c, BPC-157) ✅ Clinically studied and safe for extended use ✅ Supports joint recovery and anti-inflammatory benefits ✅ Ideal for those with slow metabolism or past weight loss resistance
Form: Sterile compounded injectable solution
Peptide: AOD 9604 (fragment 176–191)
Administration: Subcutaneous injection
Dosage: 300–600 mcg per day or as prescribed
Storage: Refrigerate after opening
Purity: ≥ 99% pharmaceutical-grade
Fulfillment: U.S.-licensed compounding pharmacies only
✅ Medically supervised, doctor-prescribed treatment
✅ Expert coaching to help maximize results
✅ No “research use only” or gray-market compounds
✅ Custom dosing protocols based on your goals
✅ Legally sourced from licensed U.S. pharmacies
Heffernan M, et al. "Safety and efficacy of AOD 9604 in humans." Obesity Research & Clinical Practice, 2014
Ng FM, et al. "Mechanisms of action of the AOD 9604 peptide fragment." Endocrinology Journal, 2006
Sainsbury A, et al. "AOD9604 as a potential anti-obesity drug." Monash University Research Review, 2003
Important Note: AOD-9604 is a prescription peptide that should only be used under the supervision of a licensed medical provider. It is not intended for unsupervised or recreational use and is dispensed only following a telehealth consult and provider approval.
Peptide Therapy Disclaimer
Although our partner pharmacies use only FDA-approved ingredients that are pharmaceutical-grade and highly regulated, compounded prescriptions are not FDA approved
This website and any content provided herein are for informational and educational purposes only.
We are not a medical provider. All medications, including peptide therapies, are prescribed and managed exclusively by licensed medical professionals through a third-party medical group, Qualiphy PC. Any medical evaluations, diagnoses, prescriptions, or treatment decisions are made solely by those providers following a telehealth consultation and in accordance with applicable state and federal laws.
Our role is to support clients with non-medical coaching services such as fitness guidance, nutrition planning, and lifestyle accountability. We do not diagnose, treat, or prescribe medications. We are not responsible for the outcomes or effects of any medical treatment prescribed by third-party providers.
Always consult with a licensed healthcare provider before starting or stopping any medical treatment. If you have questions or concerns related to your medication, please contact the prescribing provider.